Novartis

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novartis and other ETFs, options, and stocks.

About NVS

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate.

CEO

Vasant Narasimhan

CEOVasant Narasimhan

Employees

75,883

Employees75,883

Headquarters

Basel, Basel-Stadt (Basle Town)

HeadquartersBasel, Basel-Stadt (Basle Town)

Founded

1996

Founded1996

Employees

75,883

Employees75,883

NVS Key Statistics

Market cap

244.28B

Market cap244.28B

Price-Earnings ratio

16.47

Price-Earnings ratio16.47

Dividend yield

2.86%

Dividend yield2.86%

Average volume

1.96M

Average volume1.96M

High today

$116.07

High today$116.07

Low today

$114.09

Low today$114.09

Open price

$115.74

Open price$115.74

Volume

2.55M

Volume2.55M

52 Week high

$124.83

52 Week high$124.83

52 Week low

$96.06

52 Week low$96.06

NVS News

TipRanks 1d

Novartis Announces CFO Transition with Mukul Mehta’s Appointment

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Seeking Alpha 1d

Novartis CEO: Tariffs are an overhang on the pharmaceutical sector

Novartis (NYSE:NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of tariffs this year. During a CNBC inter...

Benzinga 1d

Novartis Trims Operating Income Outlook After Strong Q2 Performance, Initiates $10 Billion Stock Buyback

Swiss pharmaceutical giant Novartis AG NVS reported second-quarter 2025 earnings on Thursday and raised its full-year earnings forecast. Quarterly sales reache...

Analyst ratings

54%

of 26 ratings

Buy

23.1%

Hold

53.8%

Sell

23.1%

More NVS News

TipRanks 2d

Novartis reports Q2 EPS core $2.42, consensus $2.37

Reports Q2 revenue $14.05B, consensus $14.08B. Vas Narasimhan, CEO of Novartis (NVS), said: “Novartis delivered another strong quarter, with double-digit sales...

TipRanks 2d

Novartis announces CFO Kirsch to retire, Mehta to succeed

Novartis (NVS) announced the appointment of Mukul Mehta as the Chief Financial Officer, CFO, and a member of the Executive Committee of Novartis, ECN, effective...

Benzinga 3d

Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains'

As the Donald Trump administration plans up to 200% tariffs on pharmaceutical companies, Emily Field, head of European pharma research at Barclays, has said tha...